Regulation of Breast Cancer Cell Lines
Corresponding Organization :
Other organizations : WinnMed, Mayo Clinic, University of Otago, Mayo Clinic in Arizona, Mayo Clinic in Florida
Protocol cited in 4 other protocols
Variable analysis
- Doxycycline induction of ERβ1 expression in Hs578T-ERβ1 cells
- Doxycycline induction of ERβ1 expression in MDA-MB-231 cell lines
- Not explicitly mentioned
- Parental and ERβ1-expressing MCF7 cells
- Culture conditions (DMEM/F12 medium supplemented with 10% FBS, 1% AA, 5 mg/L blasticidin S and 500 mg/L zeocin)
- Charcoal-stripped fetal bovine serum (CS-FBS)
- Compounds: 17β-estradiol (E2), (Z)-tamoxifen, (Z)-4-hydroxy-tamoxifen, doxycycline (Dox), (Z)-endoxifen, DPN, WAY200070, FERb 033, Liquiritigenin, ICI 182,780
- Not explicitly mentioned
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!